14,992 Shares in Maximus, Inc. (NYSE:MMS) Purchased by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. purchased a new position in Maximus, Inc. (NYSE:MMS) during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 14,992 shares of the health services provider’s stock, valued at approximately $1,113,000.

Other institutional investors also recently bought and sold shares of the company. Nordea Investment Management AB acquired a new stake in shares of Maximus in the fourth quarter worth $4,618,000. Fort Washington Investment Advisors Inc. OH grew its position in Maximus by 39.1% during the 4th quarter. Fort Washington Investment Advisors Inc. OH now owns 296,476 shares of the health services provider’s stock worth $22,132,000 after purchasing an additional 83,390 shares during the period. Versor Investments LP raised its stake in shares of Maximus by 213.5% during the 3rd quarter. Versor Investments LP now owns 8,500 shares of the health services provider’s stock valued at $792,000 after buying an additional 5,789 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in shares of Maximus by 12.4% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 929,066 shares of the health services provider’s stock valued at $86,552,000 after buying an additional 102,350 shares during the period. Finally, Citigroup Inc. boosted its stake in shares of Maximus by 143.3% in the third quarter. Citigroup Inc. now owns 59,448 shares of the health services provider’s stock worth $5,538,000 after buying an additional 35,012 shares during the last quarter. 97.21% of the stock is owned by hedge funds and other institutional investors.

Maximus Price Performance

Shares of Maximus stock opened at $67.68 on Wednesday. The firm has a market cap of $3.87 billion, a PE ratio of 14.55 and a beta of 0.72. The business has a 50-day moving average price of $74.51 and a 200 day moving average price of $82.95. The company has a quick ratio of 1.49, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. Maximus, Inc. has a twelve month low of $67.20 and a twelve month high of $93.97.

Maximus (NYSE:MMS) last issued its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Sell-side analysts predict that Maximus, Inc. will post 6.05 earnings per share for the current fiscal year.

Maximus Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 28th. Investors of record on Saturday, February 15th will be given a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, February 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.77%. Maximus’s dividend payout ratio (DPR) is presently 25.81%.

Insider Activity at Maximus

In other Maximus news, insider Michelle F. Link sold 2,208 shares of the firm’s stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $73.83, for a total value of $163,016.64. Following the transaction, the insider now owns 6,567 shares in the company, valued at approximately $484,841.61. This trade represents a 25.16 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Raymond B. Ruddy bought 3,490 shares of the company’s stock in a transaction dated Thursday, December 12th. The shares were acquired at an average cost of $71.46 per share, with a total value of $249,395.40. Following the acquisition, the director now directly owns 112,520 shares of the company’s stock, valued at approximately $8,040,679.20. This represents a 3.20 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders have purchased 7,063 shares of company stock valued at $502,017. 1.60% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several research analysts recently weighed in on MMS shares. Raymond James upgraded Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price target for the company in a research report on Thursday, January 2nd. StockNews.com upgraded shares of Maximus from a “hold” rating to a “buy” rating in a research note on Thursday, February 6th.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.